Cyprotex’ H1 income down, but revs soar on US expansion
UK preclinical contractor Cyprotex says H1 profits were hit by the loss of it biggest customer, but is upbeat on revenue growth and potential of in vitro toxicity testing business.
Archives for August 24, 2011
New plant moves Irvine into Asia, gives it 2nd media source
Irvine Scientific has begun shipping from the cell culture media plant it built to expand into Asia and give clients the security of a second source.